Thursday, April 13, 2023

Bharat Biotech watching demand to resume Covaxin production

The vaccine maker had in early 2022 stopped Covaxin production amid declining demand, and claimed to have destroyed 50 million doses over the past few months

from | The Hindu https://ift.tt/fdj2sgt
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Sluggish pace of growth in revenue receipts in Telangana continue at the end of Q3

Tax revenue improves a little to cross 65% of the budget estimates during the period  from | The Hindu https://ift.tt/d8cFypm